2月4日,中国商务部宣布,将美国生物科技公司因美纳(Illumina)列入“不可靠实体清单”。商务部网站声明指出,包括因美纳在内的两家企业“违反正常市场交易原则,中断与中国企业的正常合作,采取歧视性措施严重损害中国企业合法权益”。根据《不可靠实体清单规定》第十条,中方将对该公司采取包括限制进出口、投资、人员入境、罚款等在内的多项措施。商务部在回应中强调,中方一贯审慎处理不可靠实体清单问题,仅依法...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.